August of Action Continues: Key Meetings with Sen. John Thune, Chairman Jason Smith, and Rep. Randy Feenstra

Published in Government Relations on September 03, 2024

As the August recess draws to a close, there are still ample opportunities to engage with your legislators before the upcoming election. Throughout October and leading up to the election, legislators will be back in their home states, providing a perfect window to connect with them before the end of the year. 

Below is a recap of the key meetings held over the past weeks. The consistent message from these discussions has been the urgent need for H.R.5555/S.1294 to find a legislative vehicle for passage before the year’s end. 

Ways and Means

August 19: Pat Naeger and Rose Schafhauser of MAMES organized an event with Chairman of the Ways and Means Committee, Jason Smith (MO-8). Mike “Ike” Isaacson from VGM attended as well. The event saw a significant turnout of DME suppliers and other DMEPOS industry representatives. Special thanks to Patrick Naeger for organizing this crucial event and establishing contact with a key legislator for rural communities. 

Govt relations

August 22: MAMES members, DME suppliers from South Dakota, and industry leaders from VGM (John Gallagher and Emily Harken), AAHomecare (Jay Witter), and Pride (Seth Johnson) met with Sen. John Thune in Sioux Falls, SD. Sen. Thune, a long-time supporter of the DMEPOS industry, heard attendees emphasize the critical importance of passing DME legislation (S.1294) in an end-of-year package. 

Feenstra

August 28: Choice Medical of Ames, IA, hosted a meeting with Rep. Randy Feenstra (IA-4). John Gallagher and Emily Harken from VGM also attended this event. This meeting provided an excellent opportunity to update Rep. Feenstra on the discussions from previous events. As a member of the House Ways and Means Committee, Rep. Feenstra has strong working relationships with both Republicans and Democrats. 

These meetings are timely, reinforcing the importance of passing DMEPOS legislation and improving reimbursement rates. Smith, Thune, and Feenstra have all committed to collaborating with each other and other key legislators to maintain momentum for the passage of H.R.5555/S.1294 in an end-of-year package. 

A heartfelt thank you to MAMES, all the DME suppliers, and industry representatives who attended these events. We remain hopeful that these summer meetings will lead to the successful passage of DME legislation by the end of the year. 


TAGS

  1. advocacy
  2. legislation
  3. regulatory
  4. vgm government

From Our Experts

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement. The Return of Competitive Bidding thumbnail The Return of Competitive Bidding The Centers for Medicare & Medicaid Services (CMS) appear to be laying the groundwork for another round of the Competitive Bidding Program (CBP). While full implementation will take a couple of years, an official announcement is expected this summer—potentially as early as July. Out With The Old RAC, In With The New thumbnail Out With The Old RAC, In With The New On April 28, 2025, CMS awarded Cotiviti GOV Services LLC, the new RAC Recovery Audit Contractor (RAC) Region 3, 4, and 5 contracts. RAC Region 3 includes the following Medicare Administrative Contractor (MAC) jurisdictions: JJ, JM, and JN. RAC Region 4 includes jurisdictions: JE, JF, and JL. And RAC Region 5 includes jurisdictions: JA, JB, JC, JD, as well as the HH/H MACs: J6, J15, JK, and JM.